Wang, C., Niimi, M., Watanabe, T., Wang, Y., Liang, J., & Fan, J. (2018). Treatment of atherosclerosis by traditional Chinese medicine: questions and quandaries. Atherosclerosis, 277, 136–144.

Article  CAS  PubMed  Google Scholar 

Raggi, P., Genest, J., Giles, J., Rayner, K., Dwivedi, G., & Beanlands, R., et al. (2018). Role of inflammation in the pathogenesis of atherosclerosis and therapeutic interventions. Atherosclerosis, 276, 98–108.

Article  CAS  PubMed  Google Scholar 

Oliveira, H., & Vercesi, A. (2020). Mitochondrial bioenergetics and redox dysfunctions in hypercholesterolemia and atherosclerosis. Molecular Aspects of Medicine, 71, 100840.

Article  CAS  PubMed  Google Scholar 

Chen, X., Guo, X., Ge, Q., Zhao, Y., Mu, H., & Zhang, J. (2019). ER stress activates the NLRP3 inflammasome: a novel mechanism of atherosclerosis. Oxidative Medicine Cellular Longevity, 2019, 3462530.

Article  PubMed  PubMed Central  Google Scholar 

Stachowicz, A., Olszanecki, R., & Suski, M., et al. (2014). Mitochondrial aldehyde dehydrogenase activation by Alda-1 inhibits atherosclerosis and attenuates hepatic steatosis in apolipoprotein E-knockout mice. Journal of the American Heart Association, 3(6), e001329–e001329.

Article  PubMed  PubMed Central  Google Scholar 

Xiao, G., Tang, R., Yang, N., & Chen, Y. (2023). Review on pharmacological effects of gastrodin. Archives of Pharmacal Research, 46, 744–770.

Article  CAS  PubMed  Google Scholar 

Guo, Z., Yang, X., Wu, M., Shen, A., Li, J., & Zhang, X., et al. (2023). Gastrodin attenuates angiotensin II-induced vascular contraction and MLCK/p-MLC pathway activation. Pharmaceutical Biology, 61, 858–867.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yang, C., Qiu, H., Lv, M., Yang, J., Wu, K., & Huang, J., et al. (2023). Gastrodin protects endothelial cells against high glucose-induced injury through up-regulation of PPARβ and alleviation of nitrative stress. Microvascular Research, 148, 104531.

Article  CAS  PubMed  Google Scholar 

Lu, J., Ma, X., Gao, W. C., Zhang, X., Fu, Y., Liu, Q., et al. (2021). Gastrodin exerts cardioprotective action via inhibition of insulin-like growth factor type 2/insulin-like growth factor type 2 receptor expression in cardiac hypertrophy. ACS Omega, 6, 16763–16774.

Fei, X., Cen, X., Zhao, R., Wang, J., & Cui, H. (2023). PRMT5 knockdown enhances cell viability and suppresses cell apoptosis, oxidative stress, inflammation and endothelial dysfunction in ox-LDL-induced vascular endothelial cells via interacting with PDCD4. International Immunopharmacology, 122, 110529.

Article  CAS  PubMed  Google Scholar 

Cheng, Q., Zhang, M., Zhang, M., Ning, L., Chen, D. (2020). Long non-coding RNA LOC285194 regulates vascular smooth muscle cell apoptosis in atherosclerosis. Bioengineered, 11, 53–60.

Livak, K. J., & Schmittgen, T. D. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT method. Methods, 25, 402–408.

Article  CAS  PubMed  Google Scholar 

Chereshnev, I., Trogan, E., Omerhodzic, S., Itskovich, V., Aguinaldo, J. G., & Fayad, Z. A., et al. (2003). Mouse model of heterotopic aortic arch transplantation. The Journal of Surgical Research, 111, 171–176.

Article  PubMed  Google Scholar 

Xiang, Q., Tian, F., Xu, J., Du, X., Zhang, S., Liu, L. (2022) New insight into dyslipidemia-induced cellular senescence in atherosclerosis. Biological Reviews of the Cambridge Philosophical Society, 97, 1844–1867.

Ye, T., Meng, X., Wang, R., Zhang, C., He, S. (2018) Gastrodin alleviates cognitive dysfunction and depressive-like behaviors by inhibiting ER stress and NLRP3 inflammasome activation in db/db mice. International Journal of Molecular Sciences, 19, 3977.

Ridker, P. M., & Lüscher, T. F. (2014). Anti-inflammatory therapies for cardiovascular disease. European Heart Journal, 35, 1782–1791.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Moghimpour Bijani, F., Vallejo, J. G., & Rezaei, N. (2012). Toll-like receptor signaling pathways in cardiovascular diseases: challenges and opportunities. International Reviews of Immunology, 31, 379–395.

Article  CAS  PubMed  Google Scholar 

Zhang, K., Qin, X., Qiu, J., Sun, T., Qu, K., & Din, A. U., et al. (2023). Desulfovibrio desulfuricans aggravates atherosclerosis by enhancing intestinal permeability and endothelial TLR4/NF-κB pathway in Apoe (−/−) mice. Genes & Diseases., 10, 239–253.

Article  CAS  Google Scholar 

Li, Y., Zhang, L., Ren, P., Yang, Y., Li, S., & Qin, X., et al. (2021). Qing-Xue-Xiao-Zhi formula attenuates atherosclerosis by inhibiting macrophage lipid accumulation and inflammatory response via TLR4/MyD88/NF-κB pathway regulation. Phytomedicine International Journal of Phytotherapy and Phytopharmacology, 93, 153812.

Article  CAS  PubMed  Google Scholar 

Meng, D., Deng, X., Wu, Y., Wu, J., Zhang, Y., & Zhang, J., et al. (2023). Corilagin ameliorates macrophages inflammation in atherosclerosis through TLR4-NFκB/MAPK pathway. Heliyon, 9, e16960.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cole, J. E., Kassiteridi, C., & Monaco, C. (2013). Toll-like receptors in atherosclerosis: a ‘Pandora’s box’ of advances and controversies. Trends in Pharmacological Sciences, 34, 629–636.

Article  CAS  PubMed  Google Scholar